MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease

K. Baik, Y. Lee, S. Chung, H. Yoo, J. Jung, P. Lee (Seoul, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1853

Keywords: Neuroprotective agents

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To investigate the relationship between serum uric acid (UA) and the pattern of striatal dopamine depletion in drug naïve Parkinson’s disease (PD).

Background: UA is known as an antioxidant and many studies suggest that UA could have a neuroprotective effect in PD. Epidemiological studies showed low UA concentration may increase the risk of PD. Also, longitudinal studies demonstrated an inverse association between UA and PD progression.

Method: 170 patients with drug naïve PD who underwent 18F-FP-CIT PET scans were enrolled. We quantified dopamine transporter (DAT) availability in 12 striatal subregions. The patterns of striatal dopamine depletion of each patient were assessed by (1) DAT uptake of posterior putamen (PP) in more affected side, (2) Inter-subregional ratio (ISR) which was calculated by following formula: (Striatal DAT uptake in more affected side – PP in more affected side)/PP in more affected side, (3) PP in less affected side to PP in more affected side ratio (Asymmetric ratio [AR]). Serum UA was checked at first visit to Movement clinic. Since UA differs between genders, the UA level was stratified into tertile in both male and female group separately: High level (H, UA > 5.6mg/dL), intermediate level (I, 4.5 ≤ UA  ≤ 5.6 mg/dL), low level (L, UA < 4.5 mg/dL) in male and H (UA > 4.6mg/dL), I (3.6 ≤ UA ≤ 4.6 mg/dL), L (UA < 3.6mg/dL) in female. Correlation analysis about UA in all patients and ANCOVA in female and male groups respectively were done.

Results: The average age of 170 patients was 69.3±9.82 years old, disease duration was 1.81±1.95 years and ratio of male and female was 85:85. Mean of initial UA was 4.77±1.29 mg/dL. Distributions of patients in three UA groups were L:I:H 21:29:35 in male and 22:31:32 in female group. Correlation analysis about serum UA showed significant result only with gender (Pearson correlation coefficient -0.357, p<0.01). In ANCOVA, H in male group showed low ISR (p<0.007) and high PP in affected side (p<0.031). But, there was no significant difference in AR and DAT uptake in more affected striatum. There was no significant result in female group.

Conclusion: The present data demonstrated that male patients with high level of initial UA exhibited a low anterior-posterior gradient in DAT availability with relatively preserved DAT uptake in the PP, suggesting gender-specific effect of uric acid on striatal DAT availability.

To cite this abstract in AMA style:

K. Baik, Y. Lee, S. Chung, H. Yoo, J. Jung, P. Lee. Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/relationship-between-serum-uric-acid-and-the-pattern-of-striatal-dopamine-depletion-in-de-novo-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/relationship-between-serum-uric-acid-and-the-pattern-of-striatal-dopamine-depletion-in-de-novo-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley